NO20002831L - Medikament i myk pelletform og fremgangsmÕter for fremstilling av dette - Google Patents
Medikament i myk pelletform og fremgangsmÕter for fremstilling av detteInfo
- Publication number
- NO20002831L NO20002831L NO20002831A NO20002831A NO20002831L NO 20002831 L NO20002831 L NO 20002831L NO 20002831 A NO20002831 A NO 20002831A NO 20002831 A NO20002831 A NO 20002831A NO 20002831 L NO20002831 L NO 20002831L
- Authority
- NO
- Norway
- Prior art keywords
- drug
- soft pellet
- soft
- preparing
- methods
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Otolaryngology (AREA)
- Pulmonology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Et medikament i myk pelletform egnet for inhalering som er lett å håndtere i farmasøytisk fremstilling, som ikke gir følelse av irritasjon hos brukeren og tillater kontroll av medikamentpartikkel-størrelsesfordelingen ved inhalering. Medikamentet i myk pelletform kan fremstilles ved oppløsning eller suspendering av en medisinsk forbindelse med selvagglomererende egenskaper i en væske inneholdende et sukker, slik som laktose, tørking av den dannede oppløsning eller suspensjon, pulverisering av resten og forming av den dannede pulverblanding til myke pelleter med en gjennomsnittlig partikkeldiameter fra 100 um til 1 mm ved hjelp av tromling i en rotasjonstrommel eller liknende.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP33322897 | 1997-12-03 | ||
PCT/JP1998/005159 WO1999027911A1 (fr) | 1997-12-03 | 1998-11-16 | Medicament en pastilles souples et procede de fabrication |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20002831D0 NO20002831D0 (no) | 2000-06-02 |
NO20002831L true NO20002831L (no) | 2000-08-03 |
Family
ID=18263764
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20002831A NO20002831L (no) | 1997-12-03 | 2000-06-02 | Medikament i myk pelletform og fremgangsmÕter for fremstilling av dette |
Country Status (16)
Country | Link |
---|---|
EP (1) | EP1036562A1 (no) |
KR (1) | KR20010032303A (no) |
CN (1) | CN1283991A (no) |
AR (1) | AR015491A1 (no) |
AU (1) | AU1054399A (no) |
BR (1) | BR9815345A (no) |
CA (1) | CA2310826A1 (no) |
HU (1) | HUP0004821A2 (no) |
ID (1) | ID28057A (no) |
IL (1) | IL136251A0 (no) |
NO (1) | NO20002831L (no) |
NZ (1) | NZ504711A (no) |
PL (1) | PL340736A1 (no) |
TR (1) | TR200001596T2 (no) |
WO (1) | WO1999027911A1 (no) |
ZA (1) | ZA9810882B (no) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6750324B1 (en) | 1997-12-02 | 2004-06-15 | Neuralab Limited | Humanized and chimeric N-terminal amyloid beta-antibodies |
US6905686B1 (en) | 1997-12-02 | 2005-06-14 | Neuralab Limited | Active immunization for treatment of alzheimer's disease |
US7790856B2 (en) | 1998-04-07 | 2010-09-07 | Janssen Alzheimer Immunotherapy | Humanized antibodies that recognize beta amyloid peptide |
US6787523B1 (en) | 1997-12-02 | 2004-09-07 | Neuralab Limited | Prevention and treatment of amyloidogenic disease |
TWI239847B (en) | 1997-12-02 | 2005-09-21 | Elan Pharm Inc | N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease |
US20080050367A1 (en) | 1998-04-07 | 2008-02-28 | Guriq Basi | Humanized antibodies that recognize beta amyloid peptide |
US20030147882A1 (en) | 1998-05-21 | 2003-08-07 | Alan Solomon | Methods for amyloid removal using anti-amyloid antibodies |
US6787637B1 (en) | 1999-05-28 | 2004-09-07 | Neuralab Limited | N-Terminal amyloid-β antibodies |
UA81216C2 (en) | 1999-06-01 | 2007-12-25 | Prevention and treatment of amyloid disease | |
US7807211B2 (en) | 1999-09-03 | 2010-10-05 | Advanced Cardiovascular Systems, Inc. | Thermal treatment of an implantable medical device |
US6790228B2 (en) | 1999-12-23 | 2004-09-14 | Advanced Cardiovascular Systems, Inc. | Coating for implantable devices and a method of forming the same |
US20070032853A1 (en) | 2002-03-27 | 2007-02-08 | Hossainy Syed F | 40-O-(2-hydroxy)ethyl-rapamycin coated stent |
US7700751B2 (en) | 2000-12-06 | 2010-04-20 | Janssen Alzheimer Immunotherapy | Humanized antibodies that recognize β-amyloid peptide |
ITMI20012174A1 (it) * | 2001-10-18 | 2003-04-18 | Univ Parma | Polvere per somministrazione nasale di farmaci |
MY139983A (en) | 2002-03-12 | 2009-11-30 | Janssen Alzheimer Immunotherap | Humanized antibodies that recognize beta amyloid peptide |
EP1417958A1 (en) * | 2002-11-08 | 2004-05-12 | Pari GmbH | Wet granulation process |
TWI374893B (en) | 2003-05-30 | 2012-10-21 | Janssen Alzheimer Immunotherap | Humanized antibodies that recognize beta amyloid peptide |
US20050118344A1 (en) | 2003-12-01 | 2005-06-02 | Pacetti Stephen D. | Temperature controlled crimping |
WO2005004875A1 (ja) * | 2003-07-14 | 2005-01-20 | Sankyo Company, Limited | 経肺投与用医薬組成物 |
PE20061329A1 (es) | 2004-12-15 | 2006-12-08 | Neuralab Ltd | Anticuerpos ab humanizados para mejorar la cognicion |
US8784810B2 (en) | 2006-04-18 | 2014-07-22 | Janssen Alzheimer Immunotherapy | Treatment of amyloidogenic diseases |
EP2124898B1 (en) * | 2007-01-10 | 2013-08-14 | Board of Regents, The University of Texas System | Enhanced delivery of immunosuppressive drug compositions for pulmonary delivery |
US8003097B2 (en) | 2007-04-18 | 2011-08-23 | Janssen Alzheimer Immunotherapy | Treatment of cerebral amyloid angiopathy |
SI2182983T1 (sl) | 2007-07-27 | 2014-09-30 | Janssen Alzheimer Immunotherapy | Zdravljenje amiloidogenih bolezni s humaniziranimi protitelesi proti abeta |
CN101969959A (zh) | 2007-07-31 | 2011-02-09 | 利默里克生物制药公司 | 磷酸化吡喃酮类似物和方法 |
JO3076B1 (ar) | 2007-10-17 | 2017-03-15 | Janssen Alzheimer Immunotherap | نظم العلاج المناعي المعتمد على حالة apoe |
US9067981B1 (en) | 2008-10-30 | 2015-06-30 | Janssen Sciences Ireland Uc | Hybrid amyloid-beta antibodies |
JP5872564B2 (ja) | 2011-09-14 | 2016-03-01 | 塩野義製薬株式会社 | 吸入用医薬組成物 |
TWI745396B (zh) | 2016-07-12 | 2021-11-11 | 日商鹽野義製藥股份有限公司 | 吸入用醫藥組成物 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9001635D0 (en) * | 1990-01-24 | 1990-03-21 | Ganderton David | Aerosol carriers |
JP2736168B2 (ja) * | 1992-03-10 | 1998-04-02 | フアイソンズ・ピーエルシー | 医薬製剤 |
AU4066693A (en) * | 1992-12-23 | 1994-07-19 | Bernhard Hugemann | Compacted drug body for use in the mechanical generation of inhalable active-substance particles |
JPH08291072A (ja) * | 1995-04-22 | 1996-11-05 | Kissei Pharmaceut Co Ltd | 吸入用粉末製剤用結晶とその製造方法 |
JPH08291073A (ja) * | 1995-04-22 | 1996-11-05 | Kissei Pharmaceut Co Ltd | 医薬品組成物及びその製造方法 |
-
1998
- 1998-11-16 WO PCT/JP1998/005159 patent/WO1999027911A1/ja not_active Application Discontinuation
- 1998-11-16 PL PL98340736A patent/PL340736A1/xx unknown
- 1998-11-16 AU AU10543/99A patent/AU1054399A/en not_active Abandoned
- 1998-11-16 NZ NZ504711A patent/NZ504711A/en unknown
- 1998-11-16 CN CN98813464A patent/CN1283991A/zh active Pending
- 1998-11-16 EP EP98953072A patent/EP1036562A1/en not_active Withdrawn
- 1998-11-16 BR BR9815345-5A patent/BR9815345A/pt not_active Application Discontinuation
- 1998-11-16 ID IDW20001294A patent/ID28057A/id unknown
- 1998-11-16 HU HU0004821A patent/HUP0004821A2/hu unknown
- 1998-11-16 IL IL13625198A patent/IL136251A0/xx unknown
- 1998-11-16 TR TR2000/01596T patent/TR200001596T2/xx unknown
- 1998-11-16 KR KR1020007005513A patent/KR20010032303A/ko active IP Right Grant
- 1998-11-16 CA CA002310826A patent/CA2310826A1/en not_active Abandoned
- 1998-11-27 ZA ZA9810882A patent/ZA9810882B/xx unknown
- 1998-12-02 AR ARP980106105A patent/AR015491A1/es unknown
-
2000
- 2000-06-02 NO NO20002831A patent/NO20002831L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
NO20002831D0 (no) | 2000-06-02 |
KR20010032303A (ko) | 2001-04-16 |
ID28057A (id) | 2001-05-03 |
AR015491A1 (es) | 2001-05-02 |
CN1283991A (zh) | 2001-02-14 |
WO1999027911A1 (fr) | 1999-06-10 |
IL136251A0 (en) | 2001-05-20 |
PL340736A1 (en) | 2001-02-26 |
AU1054399A (en) | 1999-06-16 |
BR9815345A (pt) | 2000-11-21 |
EP1036562A1 (en) | 2000-09-20 |
TR200001596T2 (tr) | 2000-12-21 |
NZ504711A (en) | 2002-02-01 |
HUP0004821A2 (hu) | 2001-06-28 |
ZA9810882B (en) | 1999-05-26 |
CA2310826A1 (en) | 1999-06-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20002831L (no) | Medikament i myk pelletform og fremgangsmÕter for fremstilling av dette | |
AU692550B2 (en) | Fluoxetine pharmaceutical formulations | |
CA2277913A1 (en) | New formulation for inhalation having a poured bulk density of 0.28 to 0.38 g/ml, a process for preparing the formulation and the use thereof | |
NZ535284A (en) | Microparticles of glycopyrrolate for the treatment of respiratory diseases | |
MY115688A (en) | Pharmaceutical composition for administration by inhalation | |
AU1537095A (en) | Therapeutic agents containing thyroid hormones | |
PL334493A1 (en) | Novel inhalable preparation of 0.28 to 0.38 g/ml bulk density containing budesonide | |
PL334528A1 (en) | Novel inhalable preparation of 0.28 to 0.38 g/ml bulk density containing formotherol | |
KR880004805A (ko) | 분무건조된 아세트아미노펜 | |
NO20054897L (no) | Farmasoytisk preparat inneholdende platinakompleks som aktiv substans og fremgangsmate for fremstilling derav | |
NZ236631A (en) | Process for the preparation of a spray dried powdered pharmaceutical formulation of naproxen | |
EE9900293A (et) | Uus inhaleeritav terbutaliinsulfaati sisaldav ravimvorm puistetihedusega 0,28 kuni 0,38 g/ml, selle valmistamise protsess ja kasutamine | |
DK165438B (da) | Tabletter indeholdende en hurtig dispergerbar kerne | |
JP4891081B2 (ja) | ツタの葉抽出物の製造方法および該方法により製造される抽出物 | |
ES2184561A1 (es) | Forma farmaceutica solida de administracion oral dispersable en agua para el tratamiento de la tuberculosis conteniendo refampicina, isoniazida, pirazinamida y piridoxina hidrocloruro, procedimiento para su obtencion y forma de presentacion de dicha forma farmaceutica. | |
WO2001070172A3 (es) | Forma farmaceutica solida de administracion oral dispersable en agua que comprende rifampicina, isoniazida y piridoxina hidrocloruro, procedimiento para su obtencion y forma de presentacion de dicha forma farmaceutica | |
CN1050052C (zh) | 戒烟穴贴膏 | |
CN108272904A (zh) | 一种后遗影响低的麻醉用植物提取物及其制造方法 | |
CN106798732A (zh) | 一种头孢克肟分散片及制备方法 | |
KR880012206A (ko) | 구강질환 치료 조성물 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |